Xenetic Biosciences
XBIO
NASDAQ
IPO2012
about XBIO
Xenetic Biosciences is a biopharmaceutical company focused on developing RNA-based therapies to treat cancers such as breast, ovarian, and melanoma.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $11.70 | $13.93 | $9.34 | $6.62M | 47.43M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.45 | n/a | 27.45 | -122.80% | -116.75% | 0% |